March 2026 · A letter to our angels

Thank you for
believing in us


Since your investment in August 2025, Pride Health has grown our MRR by 1.5x from $10,500 to $25,500.


This growth made possible by your support.



Read more below


We’ve achieved
Product Market Fit


You’ve bet on our mission, and the South East Asia community of >5,000 LGBTQ users, healthcare partners and NGO partnerships have validated us.


We are ready accelerate and scale up, and we need you to join us for this next chapter.


<insert logos here of AFA, Tangerine, Jekaka, Cyroviva, >

“we are ready to scale and unlock this purposeful opportunity.”



Bruce Li — CEO

01 – our metrics

Our traction and target revenue

$152,000

Revenue in last 12 months

Monthly revenue grew at 15-25% MoM

ROAs: 6.8x

Effective spends & optimisation

Driven by 50% repeat revenue and a low CAC of $52

72% of revenue from sexual health

PrEP remains our key wedge

All adjacent sexual health categories are growing along with PrEP. And the launch of new services such as GAC, HIV & Mental in 2026.

Over 5k users

>900 are paying users at a AOV of $170

220 monthly subscribers. And our Top 10% LTV users spent $400 – $2,000

$1M ARR

Projected by end of 2026

We are confident to achieve these levels of revenue and turn profitable by 2026, if we are funded for this next phase.

02 — What We Can Achieve Together

The foundation is set.
Now it’s time to scale.

We have established our regional GTM playbook with PrEP and now we are ready to go deeper into markets with adjacent services.

Now — Q1 2026

Sexual Health

A $1 billion market size for LBTQ sexual health — PrEP, Doxy-PEP, STI kits, HIV, ED.

Q2 2026

Gender Affirming Care

A >$500 million market size for transgender health from pre to post-surgical care.

Q3-4 2026

Wellness & Longevity

A fast-growing market of >$300 million for LGBTQ+ personalised wellness & longevity therapy.

03 — People

Key Leadership
Additions

Chief Growth

Sukriti Soni joins us with >20 years of senior regional commercial leader experience as BU lead from Sanofi, MSD, J&J. She has led P&L, GTM Strategies across multi-portfolio therapeutics in Asia Pacific. Starting 1st April

Chief Tech

Chris Miller is a senior tech entrepnurear that has made few exits in his own tech startups. He joins us to lead our tech team for greater agility, AI , Digital Commerce and tech deployments. Started since 1st Jan

04 — The Potential Upside

The exit playbook has been written

February 2026

Eucalyptus — an Australian digital health company built on bundled telehealth subscriptions and direct-to-consumer medications — was acquired by Hims & Hers for up to $1.15 billion USD. Founded in 2019.

A model similar to what Pride Health is building to win in SEA.

The path to acquisition is regional and global players, a very real horizon.

“We are aiming to raise at a $3.5M valuation for existing angels.

This is an exclusive round for our early supporters.

Shawn LOO –
06 — The Ask

We are offering an exclusive round

Our target is to raise $750,000, with $150,000 already secured in verbal commitments.

We are certain this is the final round we will need for a 24-month runway to reach profitability by 2026, with an Annual Recurring Revenue range of $1-3 million within the next 24 months.

ticket SIZE / commitment

$15,000

Valued at $3.5M

Your support will set us up for the $1 million ARR target by end of 2026 — the milestone that sets us up for a potential early Series A.

You will be issued a SAFE Note by Pride Health Pte Ltd at our last valuation of $3.5M — a 25% discount from the $4.5M valuation for new investors.

The Founding Team

Built by community,
Creating real impact for LGBTQ+ lives.

Bruce Li

Executive

Shawn Loo

Product

Dr. Kang Tungsanga

Medical

Sukriti Soni

Growth

Chris Miller

Technology

© Pride Health 2026.
Your Health, Our Pride.